Edwin Douglas Lephard

Title: Edwin Douglas Lephard: Innovator in Androgen-Mediated Disease Treatment

Introduction

Edwin Douglas Lephard is a notable inventor based in Montgomery, TX (US). He has made significant contributions to the field of medical science, particularly in the treatment of androgen-mediated diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Lephard holds a patent for the "Use of equol for treating androgen mediated diseases." Equol, which is the major metabolite of the phytoestrogen daidzein, has been shown to specifically bind and block the hormonal action of 5α-dihydrotestosterone (DHT) both in vitro and in vivo. This compound can bind circulating free DHT and sequester it from the androgen receptor, thereby altering growth and physiological hormone responses regulated by androgens. The implications of equol's ability to bind and sequester DHT are significant for health and disease, suggesting a broad potential for equol in the treatment and prevention of androgen-mediated pathologies.

Career Highlights

Throughout his career, Edwin Douglas Lephard has worked with esteemed institutions such as Brigham Young University and Colorado State University Research Foundation. His research has focused on the biological properties of equol and its potential applications in medical treatments.

Collaborations

Lephard has collaborated with notable colleagues, including Trent D Lund and Robert J Handa. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field of health.

Conclusion

Edwin Douglas Lephard's work in the field of androgen-mediated diseases showcases his innovative spirit and dedication to improving health outcomes. His patent on equol represents a significant advancement in medical science, with the potential to impact the treatment of various health conditions.